the uk�s initial plan had been challenged in court by the.
.
.
.
classifieds
.
..
erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the